Edit |   |
---|---|
Product Name | HEK293/Human TMPRSS2-HA-P2A-mGFP Stable Cell Line |
Description | Serine protease that proteolytically cleaves and activates the viral spike glycoproteins which facilitate virus-cell membrane fusions; spike proteins are synthesized and maintained in precursor intermediate folding states and proteolysis permits the refolding and energy release required to create stable virus-cell linkages and membrane coalescence. Facilitates human SARS coronavirus (SARS-CoV) infection via two independent mechanisms, proteolytic cleavage of ACE2, which might promote viral uptake, and cleavage of coronavirus spike glycoprotein which activates the glycoprotein for cathepsin L-independent host cell entry. Proteolytically cleaves and activates the spike glycoproteins of human coronavirus 229E (HCoV-229E) and human coronavirus EMC (HCoV-EMC) and the fusion glycoproteins F0 of Sendai virus (SeV), human metapneumovirus (HMPV), human parainfluenza 1, 2, 3, 4a and 4b viruses (HPIV). |
Size | 2 vials |
Concentration | n/a |
Applications | Useful for cell-based TMPRSS2 binding assay |
Other Names | Human |
Gene, Accession, CAS # | n/a |
Catalog # | CHEK-ATP101-2Vials |
Price | $3500 |
Order / More Info | HEK293/Human TMPRSS2-HA-P2A-mGFP Stable Cell Line from ACROBIOSYSTEMS USA |
Product Specific References | n/a |
China Office:
ACROBIOSYSTEMS China
Room 109, No. 3 Disheng Middle St., BDA,
Beijing, 100176 China
Tel: +86 400-685-2052
Fax: +86 10-5885-0566